Upgrade to SI Premium - Free Trial

Catalent (CTLT) PT Raised to $75 at JPMorgan, Following Earnings

February 3, 2020 3:09 PM

JPMorgan raised its price target on Catalent (NYSE: CTLT) to $75.00 (from $65.00) while maintaining a Overweight rating.

Categories

Analyst PT Change

Next Articles